Flatiron Health has expanded its non-small cell lung cancer Panoramic dataset with a comprehensive biomarker data model covering over 345,000 patients. The enhanced dataset includes specimen-level molecular details for guideline-recommended biomarkers such as EGFR, BRAF, KRAS, ALK, and PD-L1, along with emerging biomarkers like KEAP1 and STK11. The expansion enables researchers to examine biomarker-driven treatment patterns, patient outcomes, and testing practices across the NSCLC care journey. Each biomarker includes collection dates, test types, laboratory information, and mutation details. More than 70% of leading biopharma companies use Flatiron's NSCLC Panoramic datasets. The data supports various research applications, including real-world response assessment, machine learning risk stratification, and digital twin modelling. Flatiron's lung cancer portfolio also includes over 28,000 small cell lung cancer patients.

Healthcare data technology market: Challenges in privacy and compliance. Healthcare organizations are sitting on more data than ever before - electronic health records, connected devices, claims, imaging, and real-world evidence - and the race is on to turn that raw information into something usable. That race is fueling rapid growth in the healthcare data technology market, a space built around integrating, standardizing, securing, and monetizing health data at scale. Here's a closer look at where the market stands today, what's driving it forward, and the roadblocks still standing in the way. Key Market Facts The global healthcare data technology market was valued at USD 3.1 billion in 2024 and is projected to grow from USD 4.0 billion in 2026 to USD 9.5 billion by 2033, expanding at a compound annual growth rate of 13.4% between 2025 and 2033. A few other numbers worth noting: * North America led the market in 2024, capturing a 46.5% revenue share, while Asia Pacific is on track to be the fastest-growing region going forward. * By technology, the health data integration and monetization segment dominated in 2024, holding more than 66.55% of total revenue, as providers work to unify EHRs, clinical trial data, and real-world evidence into single, usable pipelines. * The data harmonization and structuring segment, though smaller today, is expected to post the fastest growth rate of any segment over the forecast period, largely thanks to AI and NLP tools that can standardize messy, unstructured clinical data. * EHR adoption remains the backbone of this demand: as of December 2024, roughly 88% of U.S. office-based physicians were using an EMR/EHR system, with nearly 78% on a certified platform - a base that keeps generating more data to integrate and analyze. * The competitive landscape is notably fragmented, with dozens of established and emerging vendors - including IQVIA, Veeva Systems, Oracle (Cerner), Optum, Datavant, TriNetX, and Flatiron Health - all competing for share, which keeps innovation and partnership activity high. Major Industry Trends AI and advanced analytics are moving from pilot to production. Vendors are embedding generative AI and machine learning directly into data platforms rather than treating them as add-ons. Oracle's newly launched AI Data Platform, for example, is designed to help enterprises build AI-ready data lakes and deploy AI-driven applications directly on top of unified data. Global harmonization initiatives are reshaping the data landscape. Governments and health systems are investing heavily in standardizing and connecting fragmented health records. Europe's Health Data Space regulation, formally adopted in 2025, sets a legally binding framework for cross-border health data access across the EU, covering both direct patient care and secondary research use. The UK has committed roughly £600 million toward a national Health Data Research Service, while Germany has launched a similarly ambitious medical informatics funding program - all aimed at making health data more accessible for research and care. Discover more Internet & Telecom Commercial Distribution Public Relations Interoperability is becoming a regulatory mandate, not just a best practice. In the U.S., federal regulators have intensified enforcement of information-blocking rules under the 21st Century Cures Act, pushing providers and vendors to make electronic health information more freely accessible and exchangeable. Strategic partnerships and M&A are accelerating capability-building. Rather than building every capability in-house, companies are teaming up or acquiring their way into new strengths - from IQVIA and Veeva's long-term global partnership to streamline clinical trials, to Samsung's acquisition of digital health platform Xealth, to Commvault's move to acquire data security firm Satori Cyber to strengthen protections around AI training data. Social determinants of health (SDOH) and real-world data are being folded into core platforms. Partnerships like HealthEdge and Unite Us embedding SDOH data into care management platforms reflect a broader shift toward more holistic, value-based data models that go beyond clinical records alone. Emerging technologies are tackling harmonization at scale. Graph databases, federated learning frameworks, and AI-driven semantic mapping are increasingly used to link genomic, clinical, and multi-institutional datasets - enabling collaborative research without centralizing sensitive patient data. Need data specific to your market or segment? This report can be tailored with additional countries, segments, or data points to match your exact research needs - with free customization available on purchase. Request Report Customization Primary System Challenges Data fragmentation across legacy systems. Many healthcare organizations still operate with claims, patient records, and lab results scattered across disconnected legacy systems, creating operational bottlenecks and slowing down everything from claims processing to clinical research. Regulatory complexity and compliance costs. Stringent privacy and security frameworks - HIPAA, GDPR, and a growing patchwork of regional health data governance rules - demand robust compliance and audit capabilities. While these regulations push innovation in secure data management, they also add real implementation complexity and cost for both providers and vendors. Discover more Communications & Media Studies communication Interoperability gaps between platforms. Despite widespread EHR adoption, getting different systems to talk to each other in a standardized way (HL7/FHIR and beyond) remains a persistent hurdle, particularly for organizations trying to merge imaging, genomic, and unstructured clinical data. Balancing data monetization with privacy. As organizations look to unlock value from health data - through analytics, research partnerships, or licensing - they must simultaneously protect patient privacy, driving demand for de-identification, pseudonymization, and governance tools that can slow down time-to-insight. Scalability under growing data volumes. As data volume and variety expand (from wearables, genomics, and real-world evidence), organizations need cloud-native, auto-scaling infrastructure - a shift that isn't trivial for institutions still running on manual or semi-automated processes. Regional disparities in infrastructure and investment. While North America and Europe are pushing ahead with major national data initiatives, regions like Latin America and parts of MEA are still working to modernize foundational health data infrastructure, creating uneven adoption rates globally. The bigger picture: healthcare data technology is no longer a back-office IT concern - it's becoming central to how care gets delivered, how research gets funded, and how health systems compete. Organizations that solve for interoperability, compliance, and scalability today will be the ones best positioned to capture value as the market roughly triples in size by 2033. Discover more communications Business & Industrial Want the Full Picture? See who's leading the market. Get access to detailed profiles of the key players shaping the healthcare data technology space - including IQVIA, Veeva Systems, Oracle, Optum, Datavant, and more - along with their strategies, partnerships, and market positioning. Explore Key Players Explore our dedicated business services: * U.S. Healthcare Facility Mapping & Intelligence Portal - Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities - including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs. * Brainshare Consulting - End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics. * Custom Research - Get a market intelligence report tailored to your specific requirements and aligned with your business goals. * Consumer Insights - Capture real, evolving consumer sentiment and behavior to help you make data driven strategies. * Horizon Databooks - Access the world's largest portal of Market Reports & Statistics * Investment Insights - Make investment decisions with data driven insights, powered by domain and technology * Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage. About us: Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide. Matched content.